BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28758405)

  • 1. Blood Metabolic Signatures of Body Mass Index: A Targeted Metabolomics Study in the EPIC Cohort.
    Carayol M; Leitzmann MF; Ferrari P; Zamora-Ros R; Achaintre D; Stepien M; Schmidt JA; Travis RC; Overvad K; Tjønneland A; Hansen L; Kaaks R; Kühn T; Boeing H; Bachlechner U; Trichopoulou A; Bamia C; Palli D; Agnoli C; Tumino R; Vineis P; Panico S; Quirós JR; Sánchez-Cantalejo E; Huerta JM; Ardanaz E; Arriola L; Agudo A; Nilsson J; Melander O; Bueno-de-Mesquita B; Peeters PH; Wareham N; Khaw KT; Jenab M; Key TJ; Scalbert A; Rinaldi S
    J Proteome Res; 2017 Sep; 16(9):3137-3146. PubMed ID: 28758405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular Risk Factors Associated With Blood Metabolite Concentrations and Their Alterations During a 4-Year Period in a Population-Based Cohort.
    Lacruz ME; Kluttig A; Tiller D; Medenwald D; Giegling I; Rujescu D; Prehn C; Adamski J; Frantz S; Greiser KH; Emeny RT; Kastenmüller G; Haerting J
    Circ Cardiovasc Genet; 2016 Dec; 9(6):487-494. PubMed ID: 27784734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma metabolomic profiling of amino acids and polar lipids in Iranian obese adults.
    Bagheri M; Djazayery A; Farzadfar F; Qi L; Yekaninejad MS; Aslibekyan S; Chamari M; Hassani H; Koletzko B; Uhl O
    Lipids Health Dis; 2019 Apr; 18(1):94. PubMed ID: 30967146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation of serum metabolites related to habitual diet: a targeted metabolomic approach in EPIC-Potsdam.
    Floegel A; von Ruesten A; Drogan D; Schulze MB; Prehn C; Adamski J; Pischon T; Boeing H
    Eur J Clin Nutr; 2013 Oct; 67(10):1100-8. PubMed ID: 23942179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prepregnancy Body Mass Index and Lipoprotein Fractions are Associated with Changes in Women's Serum Metabolome from Late Pregnancy to the First Months of Postpartum.
    Padilha M; Ferreira ALL; Normando P; Freire SDSR; Fiamoncini J; Brennan L; Yin X; Kac G
    J Nutr; 2023 Jan; 153(1):56-65. PubMed ID: 36913479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are Metabolic Signatures Mediating the Relationship between Lifestyle Factors and Hepatocellular Carcinoma Risk? Results from a Nested Case-Control Study in EPIC.
    Assi N; Thomas DC; Leitzmann M; Stepien M; Chajès V; Philip T; Vineis P; Bamia C; Boutron-Ruault MC; Sandanger TM; Molinuevo A; Boshuizen HC; Sundkvist A; Kühn T; Travis RC; Overvad K; Riboli E; Gunter MJ; Scalbert A; Jenab M; Ferrari P; Viallon V
    Cancer Epidemiol Biomarkers Prev; 2018 May; 27(5):531-540. PubMed ID: 29563134
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum metabolites and risk of myocardial infarction and ischemic stroke: a targeted metabolomic approach in two German prospective cohorts.
    Floegel A; Kühn T; Sookthai D; Johnson T; Prehn C; Rolle-Kampczyk U; Otto W; Weikert C; Illig T; von Bergen M; Adamski J; Boeing H; Kaaks R; Pischon T
    Eur J Epidemiol; 2018 Jan; 33(1):55-66. PubMed ID: 29181692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The blood metabolome of incident kidney cancer: A case-control study nested within the MetKid consortium.
    Guida F; Tan VY; Corbin LJ; Smith-Byrne K; Alcala K; Langenberg C; Stewart ID; Butterworth AS; Surendran P; Achaintre D; Adamski J; Amiano P; Bergmann MM; Bull CJ; Dahm CC; Gicquiau A; Giles GG; Gunter MJ; Haller T; Langhammer A; Larose TL; Ljungberg B; Metspalu A; Milne RL; Muller DC; Nøst TH; Pettersen Sørgjerd E; Prehn C; Riboli E; Rinaldi S; Rothwell JA; Scalbert A; Schmidt JA; Severi G; Sieri S; Vermeulen R; Vincent EE; Waldenberger M; Timpson NJ; Johansson M
    PLoS Med; 2021 Sep; 18(9):e1003786. PubMed ID: 34543281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective analysis of circulating metabolites and endometrial cancer risk.
    Dossus L; Kouloura E; Biessy C; Viallon V; Siskos AP; Dimou N; Rinaldi S; Merritt MA; Allen N; Fortner R; Kaaks R; Weiderpass E; Gram IT; Rothwell JA; Lécuyer L; Severi G; Schulze MB; Nøst TH; Crous-Bou M; Sánchez MJ; Amiano P; Colorado-Yohar SM; Gurrea AB; Schmidt JA; Palli D; Agnoli C; Tumino R; Sacerdote C; Mattiello A; Vermeulen R; Heath AK; Christakoudi S; Tsilidis KK; Travis RC; Gunter MJ; Keun HC
    Gynecol Oncol; 2021 Aug; 162(2):475-481. PubMed ID: 34099314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability of Serum Metabolites over a Two-Year Period: A Targeted Metabolomic Approach in Fasting and Non-Fasting Samples from EPIC.
    Carayol M; Licaj I; Achaintre D; Sacerdote C; Vineis P; Key TJ; Onland Moret NC; Scalbert A; Rinaldi S; Ferrari P
    PLoS One; 2015; 10(8):e0135437. PubMed ID: 26274920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linking diet, physical activity, cardiorespiratory fitness and obesity to serum metabolite networks: findings from a population-based study.
    Floegel A; Wientzek A; Bachlechner U; Jacobs S; Drogan D; Prehn C; Adamski J; Krumsiek J; Schulze MB; Pischon T; Boeing H
    Int J Obes (Lond); 2014 Nov; 38(11):1388-96. PubMed ID: 24608922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach.
    Floegel A; Stefan N; Yu Z; Mühlenbruch K; Drogan D; Joost HG; Fritsche A; Häring HU; Hrabě de Angelis M; Peters A; Roden M; Prehn C; Wang-Sattler R; Illig T; Schulze MB; Adamski J; Boeing H; Pischon T
    Diabetes; 2013 Feb; 62(2):639-48. PubMed ID: 23043162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.
    Corona G; Cannizzaro R; Miolo G; Caggiari L; De Zorzi M; Repetto O; Steffan A; De Re V
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Questionnaire-based self-reported nutrition habits associate with serum metabolism as revealed by quantitative targeted metabolomics.
    Altmaier E; Kastenmüller G; Römisch-Margl W; Thorand B; Weinberger KM; Illig T; Adamski J; Döring A; Suhre K
    Eur J Epidemiol; 2011 Feb; 26(2):145-56. PubMed ID: 21116839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of anthropometric markers with serum metabolites using a targeted metabolomics approach: results of the EPIC-potsdam study.
    Bachlechner U; Floegel A; Steffen A; Prehn C; Adamski J; Pischon T; Boeing H
    Nutr Diabetes; 2016 Jun; 6(6):e215. PubMed ID: 27348203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenerational cycle of obesity and diabetes: investigating possible metabolic precursors in cord blood from the PREOBE study.
    Shokry E; Marchioro L; Uhl O; Bermúdez MG; García-Santos JA; Segura MT; Campoy C; Koletzko B
    Acta Diabetol; 2019 Sep; 56(9):1073-1082. PubMed ID: 31062097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic signatures of greater body size and their associations with risk of colorectal and endometrial cancers in the European Prospective Investigation into Cancer and Nutrition.
    Kliemann N; Viallon V; Murphy N; Beeken RJ; Rothwell JA; Rinaldi S; Assi N; van Roekel EH; Schmidt JA; Borch KB; Agnoli C; Rosendahl AH; Sartor H; Huerta JM; Tjønneland A; Halkjær J; Bueno-de-Mesquita B; Gicquiau A; Achaintre D; Aleksandrova K; Schulze MB; Heath AK; Tsilidis KK; Masala G; Panico S; Kaaks R; Fortner RT; Van Guelpen B; Dossus L; Scalbert A; Keun HC; Travis RC; Jenab M; Johansson M; Ferrari P; Gunter MJ
    BMC Med; 2021 Apr; 19(1):101. PubMed ID: 33926456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Nested Case-Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Murphy N; Cross AJ; Abubakar M; Jenab M; Aleksandrova K; Boutron-Ruault MC; Dossus L; Racine A; Kühn T; Katzke VA; Tjønneland A; Petersen KE; Overvad K; Quirós JR; Jakszyn P; Molina-Montes E; Dorronsoro M; Huerta JM; Barricarte A; Khaw KT; Wareham N; Travis RC; Trichopoulou A; Lagiou P; Trichopoulos D; Masala G; Krogh V; Tumino R; Vineis P; Panico S; Bueno-de-Mesquita HB; Siersema PD; Peeters PH; Ohlsson B; Ericson U; Palmqvist R; Nyström H; Weiderpass E; Skeie G; Freisling H; Kong SY; Tsilidis K; Muller DC; Riboli E; Gunter MJ
    PLoS Med; 2016 Apr; 13(4):e1001988. PubMed ID: 27046222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood Metabolite Signatures of Metabolic Syndrome in Two Cross-Cultural Older Adult Cohorts.
    Mahajan UV; Varma VR; Huang CW; An Y; Tanaka T; Ferrucci L; Takebayashi T; Harada S; Iida M; Legido-Quigley C; Thambisetty M
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32079087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns in metabolite profile are associated with risk of more aggressive prostate cancer: A prospective study of 3,057 matched case-control sets from EPIC.
    Schmidt JA; Fensom GK; Rinaldi S; Scalbert A; Appleby PN; Achaintre D; Gicquiau A; Gunter MJ; Ferrari P; Kaaks R; Kühn T; Boeing H; Trichopoulou A; Karakatsani A; Peppa E; Palli D; Sieri S; Tumino R; Bueno-de-Mesquita B; Agudo A; Sánchez MJ; Chirlaque MD; Ardanaz E; Larrañaga N; Perez-Cornago A; Assi N; Riboli E; Tsilidis KK; Key TJ; Travis RC
    Int J Cancer; 2020 Feb; 146(3):720-730. PubMed ID: 30951192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.